Premenstrual syndrome and dysphoric disorder

American College of Obstetricians and Gynecologists. ACOG clinical practice guideline no. 7: management of premenstrual disorders. Dec 2023 [internet publication].Full text

Ismaili E, Walsh S, O'Brien PMS, et al; Consensus Group of the International Society for Premenstrual Disorders. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 Dec;19(6):953-8. Abstract

Green LJ, O’Brien PMS, Panay N, et al; Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome: green-top guideline no. 48. BJOG. 2017 Feb;124(3):e73-105.Full text  Abstract

World Health Organization. International classification of diseases 11th revision. Jan 2022 [internet publication].Full text

1. American College of Obstetricians and Gynecologists. ACOG clinical practice guideline no. 7: management of premenstrual disorders. Dec 2023 [internet publication].Full text

2. Schoep ME, Nieboer TE, van der Zanden M, et al. The impact of menstrual symptoms on everyday life: a survey among 42,879 women. Am J Obstet Gynecol. 2019 Jun;220(6):569.e1-e7. Abstract

3. Ismaili E, Walsh S, O'Brien PMS, et al; Consensus Group of the International Society for Premenstrual Disorders. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 Dec;19(6):953-8. Abstract

4. American College of Obstetricians and Gynecologists. Guidelines for women's health care: a resource manual. 4th ed. Washington, DC: American College of Obstetricians and Gynecologists; 2014:607-13.

5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022.

6. O'Brien PM, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011 Feb;14(1):13-21. Abstract

7. Green LJ, O’Brien PMS, Panay N, et al; Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome: green-top guideline no. 48. BJOG. 2017 Feb;124(3):e73-105.Full text  Abstract

8. Monagle L, Dan A, Krogh V, et al. Perimenstrual symptom prevalence rates: an Italian-American comparison. Am J Epidemiol. 1993 Dec 15;138(12):1070-81. Abstract

9. Rupani NP, Lema VM. Premenstrual tension among nurses in Nairobi, Kenya. East Afr Med J. 1993 May;70(5):310-3. Abstract

10. Sveinsdottir H, Marteinsdottir G. Retrospective assessment of premenstrual changes in Icelandic women. Health Care Women Int. 1991 Jul-Sep;12(3):303-15. Abstract

11. Vichnin M, Freeman EW, Lin H, et al. Premenstrual syndrome (PMS) in adolescents: severity and impairment. J Pediatr Adolesc Gynecol. 2006 Dec;19(6):397-402. Abstract

12. Sander B, Gordon JL. Premenstrual mood symptoms in the perimenopause. Curr Psychiatry Rep. 2021 Oct 6;23(11):73. Abstract

13. Pilver CE, Kasl S, Desai R, et al. Health advantage for black women: patterns in pre-menstrual dysphoric disorder. Psychol Med. 2011 Aug;41(8):1741-50.Full text  Abstract

14. Pilver CE, Desai R, Kasl S, et al. Lifetime discrimination associated with greater likelihood of premenstrual dysphoric disorder. J Womens Health (Larchmt). 2011 Jun;20(6):923-31.Full text  Abstract

15. Rapkin AJ, Winer SA. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res. 2009 Apr;9(2):157-70. Abstract

16. Cao S, Jones M, Tooth L, et al. Does premenstrual syndrome before pregnancy increase the risk of postpartum depression? Findings from the Australian Longitudinal Study on Women's Health. J Affect Disord. 2021 Jan 15;279:143-8. Abstract

17. Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998 Jan 22;338(4):209-16.Full text  Abstract

18. Schmidt PJ, Martinez PE, Nieman LK, et al. Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. Am J Psychiatry. 2017 Oct 1;174(10):980-9. Abstract

19. Mortola JF. Issues in the diagnosis and research of premenstrual syndrome. Clin Obstet Gynecol. 1992 Sep;35(3):587-98. Abstract

20. Steiner M, Born L. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol. 2000 Nov;15(suppl 3):S5-17. Abstract

21. Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003 Aug;28(suppl 3):25-37. Abstract

22. Andersch B, Abrahamsson L, Wendestam C, et al. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics. Clin Endocrinol (Oxf). 1979 Dec;11(6):657-64. Abstract

23. Taylor JW. Plasma progesterone, oestradiol 17 beta and premenstrual symptoms. Acta Psychiatr Scand. 1979 Jul;60(1):76-86. Abstract

24. Bertone-Johnson ER, Hankinson SE, Bendich A, et al. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med. 2005 Jun 13;165(11):1246-52. Abstract

25. Chuong CJ, Dawson EB, Smith ER. Vitamin A levels in premenstrual syndrome. Fertil Steril. 1990 Oct;54(4):643-7. Abstract

26. Chuong CJ, Dawson EB, Smith ER. Vitamin E levels in premenstrual syndrome. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1591-5. Abstract

27. Dadkhah H, Ebrahimi E, Fathizadeh N. Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: a randomized, double-blind, controlled trial. Iran J Nurs Midwifery Res. 2016 Mar-Apr;21(2):159-64.Full text  Abstract

28. Siahbazi S, Behboudi-Gandevani S, Moghaddam-Banaem L, et al. Effect of zinc sulfate supplementation on premenstrual syndrome and health-related quality of life: clinical randomized controlled trial. J Obstet Gynaecol Res. 2017 May;43(5):887-94. Abstract

29. Chocano-Bedoya PO, Manson JE, Hankinson SE, et al. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr. 2011 May;93(5):1080-6.Full text  Abstract

30. Fernández MDM, Saulyte J, Inskip HM, et al. Premenstrual syndrome and alcohol consumption: a systematic review and meta-analysis. BMJ Open. 2018 Apr 16;8(3):e019490.Full text  Abstract

31. Kendler KS, Karkowski LM, Corey LA, et al. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry. 1998 Sep;155(9):1234-40. Abstract

32. Sassoon SA, Colrain IM, Baker FC. Personality disorders in women with severe premenstrual syndrome. Arch Womens Ment Health. 2011 Jun;14(3):257-64. Abstract

33. Beck LE, Gevirtz R, Mortola JF. The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosom Med. 1990 Sep-Oct;52(5):536-43. Abstract

34. Kulkarni J, Leyden O, Gavrilidis E, et al. The prevalence of early life trauma in premenstrual dysphoric disorder (PMDD). Psychiatry Res. 2022 Feb;308:114381. Abstract

35. Prasad D, Wollenhaupt-Aguiar B, Kidd KN, et al. Suicidal risk in women with premenstrual syndrome and premenstrual dysphoric disorder: a systematic review and meta-analysis. J Womens Health (Larchmt). 2021 Dec;30(12):1693-707.Full text  Abstract

36. Budeiri DJ, Li Wan Po A, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol. 1994 Aug;101(8):689-95. Abstract

37. Muse KN, Cetel NS, Futterman LA, et al. The premenstrual syndrome: effects of "medical ovariectomy". N Engl J Med. 1984 Nov 22;311(21):1345-9. Abstract

38. Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod. 2004 Sep;19(9):2152-5.Full text  Abstract

39. Chan AF, Mortola JF, Wood SH, et al. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol. 1994 Dec;84(6):1001-5. Abstract

40. Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018 Jan;218(1):68-74. Abstract

41. Steiner M, Romano SJ, Babcock S, et al. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. BJOG. 2001 May;108(5):462-8. Abstract

42. Eriksson E. SSRIs probably counteract premenstrual syndrome by inhibiting the serotonin transporter. J Psychopharmacol. 2014 Feb;28(2):173-4. Abstract

43. Giannini AJ, Martin DM, Turner CE. Beta-endorphin decline in late luteal phase dysphoric disorder. Int J Psychiatry Med. 1990;20(3):279-84. Abstract

44. Wardlaw SL, Thoron L, Frantz AG. Effects of sex steroids on brain beta-endorphin. Brain Res. 1982 Aug 12;245(2):327-31. Abstract

45. Chuong CJ, Hsi BP, Gibbons WE. Periovulatory beta-endorphin levels in premenstrual syndrome. Obstet Gynecol. 1994 May;83(5 Pt 1):755-60. Abstract

46. Rojansky N, Halbreich U, Zander K, et al. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest. 1991;31(3):146-52. Abstract

47. Eriksson E, Alling C, Andersch B, et al. Cerebrospinal fluid levels of monoamine metabolites: a preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Neuropsychopharmacology. 1994 Nov;11(3):201-13. Abstract

48. Gracia CR, Freeman EW, Sammel MD, et al. Allopregnanolone levels before and after selective serotonin reuptake inhibitor treatment of premenstrual symptoms. J Clin Psychopharmacol. 2009 Aug;29(4):403-5. Abstract

49. Miller A, Vo H, Huo L, et al. Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls. J Psychiatr Res. 2010 Sep;44(12):788-94.Full text  Abstract

50. Dubey N, Hoffman JF, Schuebel K, et al. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Mol Psychiatry. 2017 Aug;22(8):1172-84.Full text  Abstract

51. Cohen LS, Soares CN, Otto MW, et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women: the Harvard study of moods and cycles. J Affect Disord. 2002 Jul;70(2):125-32. Abstract

52. Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder. Psychosom Med. 1994 May-Jun;56(3):225-31. Abstract

53. Graze KK, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand. 1990 Feb;81(2):201-5. Abstract

54. Eisenlohr-Moul TA, Rubinow DR, Schiller CE, et al. Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder. Psychoneuroendocrinology. 2016 May;67:142-52.Full text  Abstract

55. Girdler SS, Leserman J, Bunevicius R, et al. Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder. Health Psychol. 2007 Mar;26(2):201-13.Full text  Abstract

56. Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006 Jan;9(1):41-9. Abstract

57. Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med. 1999 Mar-Apr;8(2):122-8. Abstract

58. Mortola JF, Girton L, Beck L, et al. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990 Aug;76(2):302-7. Abstract

59. World Health Organization. International classification of diseases 11th revision. Jan 2022 [internet publication].Full text

60. Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al. Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS). Am J Psychiatry. 2017 Jan 1;174(1):51-9.Full text  Abstract

61. International Association For Premenstrual Disorders (IAPMD). Evidence-based management of premenstrual disorders (PMDs). Nov 2020 [internet publication].Full text

62. Daley A. The role of exercise in the treatment of menstrual disorders: the evidence. Br J Gen Pract. 2009 Apr;59(561):241-2.Full text  Abstract

63. Steege JF, Blumenthal JA. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res. 1993;37(2):127-33. Abstract

64. Stoddard JL, Dent CW, Shames L, et al. Exercise training effects on premenstrual distress and ovarian steroid hormones. Eur J Appl Physiol. 2007 Jan;99(1):27-37. Abstract

65. Mohebbi Dehnavi Z, Jafarnejad F, Sadeghi Goghary S. The effect of 8 weeks aerobic exercise on severity of physical symptoms of premenstrual syndrome: a clinical trial study. BMC Womens Health. 2018 May 31;18(1):80.Full text  Abstract

66. Armour M, Ee CC, Naidoo D, et al. Exercise for dysmenorrhoea. Cochrane Database Syst Rev. 2019 Sep 20;(9):CD004142.Full text  Abstract

67. Tsai SY. Effect of yoga exercise on premenstrual symptoms among female employees in Taiwan. Int J Environ Res Public Health. 2016 Jul 16;13(7):721.Full text  Abstract

68. Bertone-Johnson ER, Hankinson SE, Willett WC, et al. Adiposity and the development of premenstrual syndrome. J Womens Health (Larchmt). 2010 Nov;19(11):1955-62.Full text  Abstract

69. Mizgier M, Jarzabek-Bielecka G, Jakubek E, et al. The relationship between body mass index, body composition and premenstrual syndrome prevalence in girls. Ginekol Pol. 2019;90(5):256-61.Full text  Abstract

70. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998 Aug;179(2):444-52. Abstract

71. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009 Fall;16(3):e407-29. Abstract

72. Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999 May 22;318(7195):1375-81.Full text  Abstract

73. Jafari F, Tarrahi MJ, Farhang A, et al. Effect of zinc supplementation on quality of life and sleep quality in young women with premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. Arch Gynecol Obstet. 2020 Sep;302(3):657-64. Abstract

74. Hunter MS, Ussher JM, Browne SJ, et al. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol. 2002 Sep;23(3):193-9. Abstract

75. Lustyk MK, Gerrish WG, Shaver S, et al. Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2009 Apr;12(2):85-96. Abstract

76. Ussher JM, Perz J. Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for premenstrual disorders (PMDs), in comparison to one-to-one CBT and a wait list control: a randomized controlled trial. PLoS One. 2017 Apr 18;12(4):e0175068.Full text  Abstract

77. Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006586.Full text  Abstract

78. Ma S, Song SJ. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2023 Jun 23;6(6):CD006586.Full text  Abstract

79. Freeman EW, Halbreich U, Grubb GS, et al. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception. 2012 May;85(5):437-45. Abstract

80. American College of Obstetricians and Gynecologists. ACOG committee opinion number 540: risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Obstet Gynecol. 2012 Nov;120(5):1239-42.Full text  Abstract

81. Marjoribanks J, Brown J, O'Brien PM, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013 Jun 7;(6):CD001396.Full text  Abstract

82. Freeman EW, Sammel MD, Lin H, et al. Clinical subtypes of premenstrual syndrome and responses to sertraline treatment. Obstet Gynecol. 2011 Dec;118(6):1293-300.Full text  Abstract

83. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. Abstract

84. Mitwally MF, Kahn LS, Halbreich U. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices. Expert Opin Pharmacother. 2002 Nov;3(11):1577-90. Abstract

85. İlhan G, Verit Atmaca FV, Kurek Eken M, et al. Premenstrual syndrome is associated with a higher frequency of female sexual difficulty and sexual distress. J Sex Marital Ther. 2017 Nov 17;43(8):811-21. Abstract

86. Smith RN, Studd JW, Zamblera D, et al. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol. 1995 Jun;102(6):475-84. Abstract

87. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010 Jan;115(1):206-18. Abstract

88. Naheed B, Kuiper JH, Uthman OA, et al. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome. Cochrane Database Syst Rev. 2017 Mar 3;(3):CD010503.Full text  Abstract

89. Di Carlo C, Palomba S, Tommaselli GA, et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril. 2001 Feb;75(2):380-4. Abstract

90. Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab. 1991 Feb;72(2):252A-F. Abstract

91. Pearlstein T. Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause Int. 2012 Jun;18(2):60-4. Abstract

92. Krunic A, Ciurea A, Scheman A. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone. J Am Acad Dermatol. 2008 Jan;58(1):60-2. Abstract

93. Aydin Y, Atis A, Kaleli S, et al. Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study. Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):203-6. Abstract

94. Behboodi Moghadam Z, Rezaei E, Shirood Gholami R, et al. The effect of Valerian root extract on the severity of pre menstrual syndrome symptoms. J Tradit Complement Med. 2016 Jan 19;6(3):309-15.Full text  Abstract

95. Jang SH, Kim DI, Choi MS. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement Altern Med. 2014 Jan 10;14:11.Full text  Abstract

96. Kim SY, Park HJ, Lee H, et al. Acupuncture for premenstrual syndrome: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2011 Jul;118(8):899-915. Abstract

97. Dvivedi J, Dvivedi S, Mahajan KK, et al. Effect of '61-points relaxation technique' on stress parameters in premenstrual syndrome. Indian J Physiol Pharmacol. 2008 Jan-Mar;52(1):69-76. Abstract

98. Goodale IL, Domar AD, Benson H. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol. 1990 Apr;75(4):649-55. Abstract

99. Oleson T, Flocco W. Randomized controlled study of premenstrual symptoms treated with ear, hand, and foot reflexology. Obstet Gynecol. 1993 Dec;82(6):906-11. Abstract

100. Dimmock PW, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000 Sep 30;356(9236):1131-6. Abstract